Literature DB >> 26170310

Three-dimensional model of surfactant replacement therapy.

Marcel Filoche1, Cheng-Feng Tai2, James B Grotberg3.   

Abstract

Surfactant replacement therapy (SRT) involves instillation of a liquid-surfactant mixture directly into the lung airway tree. It is widely successful for treating surfactant deficiency in premature neonates who develop neonatal respiratory distress syndrome (NRDS). However, when applied to adults with acute respiratory distress syndrome (ARDS), early successes were followed by failures. This unexpected and puzzling situation is a vexing issue in the pulmonary community. A pressing question is whether the instilled surfactant mixture actually reaches the adult alveoli/acinus in therapeutic amounts. In this study, to our knowledge, we present the first mathematical model of SRT in a 3D lung structure to provide insight into answering this and other questions. The delivery is computed from fluid mechanical principals for 3D models of the lung airway tree for neonates and adults. A liquid plug propagates through the tree from forced inspiration. In two separate modeling steps, the plug deposits a coating film on the airway wall and then splits unevenly at the bifurcation due to gravity. The model generates 3D images of the resulting acinar distribution and calculates two global indexes, efficiency and homogeneity. Simulating published procedural methods, we show the neonatal lung is a well-mixed compartment, whereas the adult lung is not. The earlier, successful adult SRT studies show comparatively good index values implying adequate delivery. The later, failed studies used different protocols resulting in very low values of both indexes, consistent with inadequate acinar delivery. Reasons for these differences and the evolution of failure from success are outlined and potential remedies discussed.

Entities:  

Keywords:  biological fluid mechanics; biological transport processes; pulmonary drug delivery; respiratory distress syndrome; surfactant replacement therapy

Mesh:

Substances:

Year:  2015        PMID: 26170310      PMCID: PMC4522812          DOI: 10.1073/pnas.1504025112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A rat lung model of instilled liquid transport in the pulmonary airways.

Authors:  K J Cassidy; J L Bull; M R Glucksberg; C A Dawson; S T Haworth; R Hirschl; N Gavriely; J B Grotberg
Journal:  J Appl Physiol (1985)       Date:  2001-05

Review 2.  Exogenous surfactant as a drug delivery agent.

Authors:  J J Haitsma; U Lachmann; B Lachmann
Journal:  Adv Drug Deliv Rev       Date:  2001-04-25       Impact factor: 15.470

3.  Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.

Authors:  W Bernhard; J Mottaghian; A Gebert; G A Rau; H von Der HARDT; C F Poets
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 4.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

5.  Bulk shear viscosities of endogenous and exogenous lung surfactants.

Authors:  David M King; Zhengdong Wang; Harvey J Palmer; Bruce A Holm; Robert H Notter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-02       Impact factor: 5.464

6.  Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics.

Authors:  D Walmrath; F Grimminger; D Pappert; C Knothe; U Obertacke; A Benzing; A Günther; T Schmehl; H Leuchte; W Seeger
Journal:  Eur Respir J       Date:  2002-05       Impact factor: 16.671

7.  Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.

Authors:  Roger G Spragg; Friedemann J H Taut; James F Lewis; Peter Schenk; Clemens Ruppert; Nathan Dean; Kenneth Krell; Andreas Karabinis; Andreas Günther
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

8.  Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.

Authors:  Roger G Spragg; James F Lewis; Hans-Dieter Walmrath; Jay Johannigman; Geoff Bellingan; Pierre-Francois Laterre; Michael C Witte; Guy A Richards; Gerd Rippin; Frank Rathgeb; Dietrich Häfner; Friedemann J H Taut; Werner Seeger
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

9.  Effect of ventilation rate on instilled surfactant distribution in the pulmonary airways of rats.

Authors:  Joseph C Anderson; Robert C Molthen; Christopher A Dawson; Steve T Haworth; Joseph L Bull; Matthew R Glucksberg; James B Grotberg
Journal:  J Appl Physiol (1985)       Date:  2004-02-27

10.  An optimal bronchial tree may be dangerous.

Authors:  B Mauroy; M Filoche; E R Weibel; B Sapoval
Journal:  Nature       Date:  2004-02-12       Impact factor: 49.962

View more
  22 in total

1.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

2.  Did Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome?

Authors:  James B Grotberg; Marcel Filoche; Douglas F Willson; Krishnan Raghavendran; Robert H Notter
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

3.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

4.  A Macroscopic Model for Simulating the Mucociliary Clearance in a Bronchial Bifurcation: The Role of Surface Tension.

Authors:  Michail Manolidis; Daniel Isabey; Bruno Louis; James B Grotberg; Marcel Filoche
Journal:  J Biomech Eng       Date:  2016-12-01       Impact factor: 2.097

5.  In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.

Authors:  Francesca Ricci; Chiara Catozzi; Francesca Ravanetti; Xabier Murgia; Francesco D'Aló; Natalia Macchidani; Elisa Sgarbi; Valentina Di Lallo; Federica Saccani; Marisa Pertile; Antonio Cacchioli; Silvia Catinella; Gino Villetti; Maurizio Civelli; Francesco Amadei; Fabio Franco Stellari; Barbara Pioselli; Fabrizio Salomone
Journal:  Pediatr Res       Date:  2017-08-23       Impact factor: 3.756

6.  A Three-Dimensional Model of Human Lung Airway Tree to Study Therapeutics Delivery in the Lungs.

Authors:  Antonio Copploe; Morteza Vatani; Jae-Won Choi; Hossein Tavana
Journal:  Ann Biomed Eng       Date:  2019-03-11       Impact factor: 3.934

7.  Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.

Authors:  Amy Z Stetten; Steven V Iasella; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  Curr Opin Colloid Interface Sci       Date:  2018-01-13       Impact factor: 6.448

Review 8.  Lung Structure and the Intrinsic Challenges of Gas Exchange.

Authors:  Connie C W Hsia; Dallas M Hyde; Ewald R Weibel
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

9.  Sulforhodamine B and exogenous surfactant effects on alveolar surface tension under acute respiratory distress syndrome conditions.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2020-09-24

10.  Intravenous sulforhodamine B reduces alveolar surface tension, improves oxygenation, and reduces ventilation injury in a respiratory distress model.

Authors:  You Wu; Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.